Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Acetylcysteine, also known as N-acetylcysteine (NAC), is a medication that is used to treat paracetamol (acetaminophen) overdose, and to loosen thick mucus in individuals with chronic bronchopulmonary disorders like pneumonia and bronchitis. Acetylcysteine was initially patented in 1960 and came into medical use in 1968. Its product, FLUIMUCIL was developed by Zambon Italia Srl. Acetylcysteine was approved in China in 2002. By the half past of 2021, in addition to Zambon Italia Srl, there are more than 10 generic drug manufacturers in the Chinese Acetylcysteine market, such as Hangzhou Minsheng Pharmaceutical Co.,Ltd., Hainan Star Pharmaceutical Co., Ltd. and Ruiyang Pharmaceutical Co., Ltd.
According to CRI analysis, the sales value of Acetylcysteine has grown rapidly from 2016 to 2019 in China, with the highest Year-on-Year growth rate of 47.93% in 2019. In 2020, the sales value of Acetylcysteine increased by about 8.84% to CNY 1.016 billion in China. The main reason is that the Covid-19 epidemic has affected the hospital's overall diagnosis and treatment business, resulting in a decline in its growth rate. The CAGR of Acetylcysteine’s sales value in the Chinese market from 2016 to 2020 is 24.74%.
Researcher predicts that the sales of Acetylcysteine in the Chinese market will have a restorative growth from 2021 to 2025 with the effective alleviation of the Covid-19 epidemic. In addition, Kangyuan Pharmaceutical submitted an application of Acetylcysteine solution for inhalation for marketing authorization on March 16 2021. It is expected that the price of acetylcysteine will decrease with the addition of new manufacturers. There is room for growth in both sales volume and sales.
Topics Covered:
-The impact of COVID-19 on China's Acetylcysteine market
- Sales value of China's Acetylcysteine 2016-2020
- Competitive landscape of China's Acetylcysteine market
- Prices of Acetylcysteine in China
- Prices of Acetylcysteine in China by regions and manufacturers
- Analysis on factors affecting the development of China's Acetylcysteine market
- Prospect of China's Acetylcysteine market from 2021 to 2025
According to CRI analysis, the sales value of Acetylcysteine has grown rapidly from 2016 to 2019 in China, with the highest Year-on-Year growth rate of 47.93% in 2019. In 2020, the sales value of Acetylcysteine increased by about 8.84% to CNY 1.016 billion in China. The main reason is that the Covid-19 epidemic has affected the hospital's overall diagnosis and treatment business, resulting in a decline in its growth rate. The CAGR of Acetylcysteine’s sales value in the Chinese market from 2016 to 2020 is 24.74%.
Researcher predicts that the sales of Acetylcysteine in the Chinese market will have a restorative growth from 2021 to 2025 with the effective alleviation of the Covid-19 epidemic. In addition, Kangyuan Pharmaceutical submitted an application of Acetylcysteine solution for inhalation for marketing authorization on March 16 2021. It is expected that the price of acetylcysteine will decrease with the addition of new manufacturers. There is room for growth in both sales volume and sales.
Topics Covered:
-The impact of COVID-19 on China's Acetylcysteine market
- Sales value of China's Acetylcysteine 2016-2020
- Competitive landscape of China's Acetylcysteine market
- Prices of Acetylcysteine in China
- Prices of Acetylcysteine in China by regions and manufacturers
- Analysis on factors affecting the development of China's Acetylcysteine market
- Prospect of China's Acetylcysteine market from 2021 to 2025
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
